Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00043758
Collaborator
(none)
170
40
24
4.3
0.2

Study Details

Study Description

Brief Summary

The purpose of this study is to study the effects of tolvaptan on the size and function of the left heart chamber (ventricle) in patients with congestive heart failure (CHF)

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Study Start Date :
Jul 1, 2002
Study Completion Date :
Jul 1, 2004

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    History of congestive heart failure

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Desert Cardiology of Tucson Tucson Arizona United States 85741
    2 Arkansas Heart Little Rock Arkansas United States 72211
    3 San Diego Cardiac Center San Diego California United States 92123
    4 Northern California Medical Associates Santa Rosa California United States 95403
    5 Cardiovascular Consultants Medical Group, Inc. Walnut Creek California United States 94598
    6 University of Colorado Denver Colorado United States 80262
    7 The Hoffman Heart Institute of CT/St. Francis Hospital Hartford Connecticut United States 06105
    8 Yale University New Haven Connecticut United States 06510
    9 Cardiology Associates of Fort Lauderdale Fort Lauderdale Florida United States 33308
    10 Cardiovascular Research Center of South Florida Miami Florida United States 33173
    11 Charlotte Heart Group Port Charlotte Florida United States 33952
    12 The Heart and Vascular Institute of Florida St. Petersburg Florida United States 33701
    13 Cardiovascular Associates of Augusta, PA Augusta Georgia United States 30901
    14 Georgia Heart Specialists Covington Georgia United States 30014
    15 Illinois Heart and Lung Associates, SC Normal Illinois United States 61761
    16 The Care Group, LLC Indianapolis Indiana United States 46260
    17 Medical Research Institute Slidell Louisiana United States 70458
    18 Androscoggin Cardiology Associates Auburn Maine United States 04210
    19 Maine Cardiology Associates Portland Maine United States 04102
    20 Pentucket Medical Associates Haverhill Massachusetts United States 01839
    21 Mystic Cardiology Associates, Inc. Medford Massachusetts United States 02155
    22 Harper Hospital/Wayne State University Detroit Michigan United States 48201
    23 John Dingell VA Medical Center Detroit Michigan United States 48201
    24 St. Luke's-Roosevelt Hospital Center New York New York United States 10025
    25 South Bay Cardiovascular Associates West Islip New York United States 11795
    26 The Lindner Clinical Trial Center Cincinnati Ohio United States 45219
    27 Midwest Cardiology Research Foundation Columbus Ohio United States 43202
    28 North Ohio Research LTD Lorraine Ohio United States 44053
    29 North Ohio Research LTD. Sandusky Ohio United States 44870
    30 Medical College of Pennsylvania Philadelphia Pennsylvania United States 19129
    31 Guthrie Clinic, LTD Sayre Pennsylvania United States 18840
    32 Miriam Hospital Providence Rhode Island United States 02905
    33 University Cardiology Foundation Providence Rhode Island United States 02905
    34 Ralph H. Johnson VAMC Charleston South Carolina United States 29401
    35 Stern Cardiovascular Center Memphis Tennessee United States 38120
    36 Health Sciences Center Winnipeg Manitoba Canada R3A 1R9
    37 Health Sciences Center Memorial University of Newfoundland St. John's Newfoundland and Labrador Canada A1B 3V6
    38 London Health Sciences Center London Ontario Canada N6A 4G5
    39 St. Michael's Hospital Toronto Ontario Canada M5B 1W8
    40 The Toronto Hospital Toronto Ontario Canada M5G 2C4

    Sponsors and Collaborators

    • Otsuka Pharmaceutical Development & Commercialization, Inc.

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00043758
    Other Study ID Numbers:
    • 156-01-232
    First Posted:
    Aug 14, 2002
    Last Update Posted:
    Jun 24, 2005
    Last Verified:
    Jun 1, 2005
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 24, 2005